B Cell Receptor (BCR) Cross-Talk: CD40 Engagement Enhances BCR-Induced ERK Activation1

Bystander B cells may be initially stimulated through CD40, which enhances susceptibility to Fas-mediated apoptosis, before encountering Ag, which produces Fas resistance. A key issue in this process is to what extent CD40 cross-talk might affect subsequent BCR signaling. It has previously been shown that CD40 engagement bypasses or mitigates the need for Bruton’s tyrosine kinase in subsequent BCR signaling for NF-κB activation. However, the full extent of the effects of CD40 on BCR signaling has not been delineated. In the present study we evaluated the possibility that CD40-mediated cross-talk also affects another principal outcome of BCR signaling: MAPK activation. We found that prior stimulation of primary murine B cells with CD40L markedly enhanced the level of ERK and JNK (but not p38 MAPK) phosphorylation produced by subsequently added anti-Ig Ab, and much, but not all, of this enhancement was independent of PI3K and phospholipase C. CD40L treatment similarly enhanced BCR-induced MAPK kinase (MEK) phosphorylation, and MEK was required for enhancement of ERK. Although BCR-induced c-Raf phosphorylation was also enhanced by prior CD40L treatment, c-Raf was not required for MEK/ERK phosphorylation. These results identify a novel system of receptor cross-talk between CD40 and BCR and indicate that the effects of CD40 engagement on subsequent BCR stimulation spread beyond NF-κB to involve the MAPK pathway.

[1]  H. Nakano,et al.  Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 , 1998 .

[2]  H. Niiro,et al.  Decision making in the immune system: Regulation of B-cell fate by antigen-receptor signals , 2002, Nature Reviews Immunology.

[3]  T. Kurosaki,et al.  Involvement of Guanosine Triphosphatases and Phospholipase C-γ2 in Extracellular Signal–regulated Kinase, c-Jun NH2-terminal Kinase, and p38 Mitogen-activated Protein Kinase Activation by the B Cell Antigen Receptor , 1998, The Journal of experimental medicine.

[4]  J. Penninger,et al.  Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. , 2003, Immunity.

[5]  R. Noelle,et al.  CD40-CD154 interactions in B-cell signaling. , 2000, Current topics in microbiology and immunology.

[6]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[7]  Robert H. Silverman,et al.  Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.

[8]  J. Karras,et al.  Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. , 1995, International immunology.

[9]  I. Weissman,et al.  Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. , 1998, Immunity.

[10]  N. Yoshida,et al.  Enhanced and accelerated lymphoproliferation in Fas-null mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Kurosaki,et al.  Different Protein Tyrosine Kinases Are Required for B Cell Antigen Receptor–mediated Activation of Extracellular Signal–Regulated kinase, c-Jun NH2-terminal Kinase 1, and p38 Mitogen-activated Protein Kinase , 1998, The Journal of experimental medicine.

[12]  J. Tschopp,et al.  CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation , 2002, Nature Immunology.

[13]  A. Lanzavecchia,et al.  Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation , 1993, The Journal of experimental medicine.

[14]  L. Santos‐Argumedo,et al.  Enforced and prolonged CD40 ligand expression triggers autoantibody production in vivo , 2001, European journal of immunology.

[15]  H. Niiro,et al.  Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. , 2003, Immunity.

[16]  F. Hobbs,et al.  Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.

[17]  R. Flavell,et al.  Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor , 1996, Cell.

[18]  M. Nussenzweig,et al.  Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. , 2003, Immunity.

[19]  R. Carter,et al.  Convergence of CD 19 and B Cell Antigen Receptor Signals at MEK 1 in the ERK 2 Activation Cascade 1 , 1998 .

[20]  P. Wollenzien,et al.  Short-range RNA-RNA crosslinking methods to determine rRNA structure and interactions. , 2001, Methods.

[21]  J. Cambier,et al.  B cell development: signal transduction by antigen receptors and their surrogates. , 1999, Current opinion in immunology.

[22]  T. Rothstein,et al.  NF-κB Is Required for Surface Ig-Induced Fas Resistance in B Cells1 , 2003, The Journal of Immunology.

[23]  T. J. Donohoe,et al.  Receptor‐specific regulation of B‐cell susceptibility to Fas‐mediated apoptosis and a novel Fas apoptosis inhibitory molecule , 2000, Immunological reviews.

[24]  A. Tordai,et al.  Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes. , 1994, The Journal of biological chemistry.

[25]  G. Kelsoe,et al.  In Situ Studies of the Primary Immune Response to (4-Hydroxy-3-Nitrophenyl)Acetyl. V. Affinity Maturation Develops in Two Stages of Clonal Selection , 1998, The Journal of experimental medicine.

[26]  E. Génot,et al.  Ras regulation and function in lymphocytes. , 2000, Current opinion in immunology.

[27]  M. Taniguchi,et al.  Distinct subcellular localization and substrate specificity of extracellular signal-regulated kinase in B cells upon stimulation with IgM and CD40. , 1999, Journal of immunology.

[28]  B. Marinari,et al.  Mitogen‐activated kinase kinase kinase 1 regulates T cell receptor‐ and CD28‐mediated signaling events which lead to NF‐κB activation , 2000, European journal of immunology.

[29]  C. Crews,et al.  The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. , 1992, Science.

[30]  A. Jacob,et al.  Convergence of Signaling Pathways on the Activation of ERK in B Cells* , 2002, The Journal of Biological Chemistry.

[31]  T. Mizuno,et al.  Cutting Edge: CD40 Engagement Eliminates the Need for Bruton’s Tyrosine Kinase in B Cell Receptor Signaling for NF-κB1 , 2003, The Journal of Immunology.

[32]  A. Richmond,et al.  Nuclear Factor-κB Activation by the CXC Chemokine Melanoma Growth-stimulatory Activity/Growth-regulated Protein Involves the MEKK1/p38 Mitogen-activated Protein Kinase Pathway* , 2001, The Journal of Biological Chemistry.

[33]  F. Alt,et al.  Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.

[34]  R. Carter,et al.  Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade. , 1998, Journal of immunology.

[35]  W. Khan,et al.  Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement , 2000, The Journal of experimental medicine.

[36]  T. Wirth,et al.  Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[38]  T. Kurosaki,et al.  Genetic analysis of B cell antigen receptor signaling. , 1999, Annual review of immunology.

[39]  R. Woodland,et al.  BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton’s Tyrosine Kinase1 , 2002, The Journal of Immunology.

[40]  J. Kapp,et al.  Bystander help in primary immune responses in vivo , 1986, The Journal of experimental medicine.

[41]  C. Hackett,et al.  Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand. , 1996, Cellular immunology.

[42]  E. Gelfand,et al.  Differential activation and regulation of mitogen‐activated protein kinases through the antigen receptor and CD40 in human B cells , 1999, European journal of immunology.

[43]  T. Randall,et al.  The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression , 2002, The Journal of experimental medicine.

[44]  P. Krammer,et al.  CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway , 1995, The Journal of experimental medicine.

[45]  Shigeo Ohno,et al.  Protein Kinase C δ Activates the MEK-ERK Pathway in a Manner Independent of Ras and Dependent on Raf* , 1996, The Journal of Biological Chemistry.

[46]  B Zheng,et al.  Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. , 1995, Journal of immunology.

[47]  Chris Bakal,et al.  The MAGUK family protein CARD11 is essential for lymphocyte activation. , 2003, Immunity.

[48]  D. Parker,et al.  Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. , 1998, Journal of immunology.

[49]  H. Wortis,et al.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. J. Taylor,et al.  Nonradioactive determination of Ras-GTP levels using activated ras interaction assay. , 2001, Methods in enzymology.

[51]  T. Chiles,et al.  Requirement for a hsp90 Chaperone-dependent MEK1/2-ERK Pathway for B Cell Antigen Receptor-induced Cyclin D2 Expression in Mature B Lymphocytes* , 2002, The Journal of Biological Chemistry.

[52]  R. Sen,et al.  Bruton's Tyrosine Kinase Links the B Cell Receptor to Nuclear Factor κb Activation , 2000, The Journal of experimental medicine.

[53]  P. Krammer,et al.  Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis , 1996, The Journal of experimental medicine.

[54]  J. Kutok,et al.  B cell receptor signal strength determines B cell fate , 2004, Nature Immunology.

[55]  G. Bishop,et al.  CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. , 1996, Journal of immunology.

[56]  T. Kadowaki,et al.  Phosphatidylinositol 3-Kinase and NF-κB/Rel Are at the Divergence of CD40-Mediated Proliferation and Survival Pathways , 2000, The Journal of Immunology.

[57]  C. Marshall,et al.  Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. , 1998, Science.

[58]  T. Maniatis,et al.  Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.

[59]  S. Ju,et al.  Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells , 1995, Nature.

[60]  M. Farrar,et al.  Control of B cell development by Ras‐mediated activation of Raf , 1997, The EMBO journal.

[61]  H. Bone,et al.  Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells. , 2001, International immunology.

[62]  A. DeFranco,et al.  Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen1 , 2001, The Journal of Immunology.

[63]  T. Rothstein,et al.  Peritoneal and splenic B‐1 cells are separable by phenotypic, functional, and transcriptomic characteristics , 2004, European journal of immunology.

[64]  L. Neckers,et al.  Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway , 1996, Molecular and cellular biology.

[65]  T. Behrens,et al.  PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction , 2003, Nature Immunology.

[66]  G. Crabtree,et al.  Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. , 1997, Immunity.

[67]  J. Monroe,et al.  Immunobiology of the immature B cell: plasticity in the B‐cell antigen receptor‐induced response fine tunes negative selection , 2000, Immunological reviews.

[68]  M. Reth,et al.  Inducible gene deletion reveals different roles for B‐Raf and Raf‐1 in B‐cell antigen receptor signalling , 2002, The EMBO journal.